During the past decade, A.O. Universitaria Policlinico Di Modena; Oncologia conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "A.O. Universitaria Policlinico Di Modena; Oncologia" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 11 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 4 trials sponsored, "Gruppo Italiano Studio Linfomi" with 2 trials sponsored and "Gruppo Oncologico Italiano di Ricerca Clinica" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "A.O. Universitaria Policlinico Di Modena; Oncologia" #1 collaborator was "Clirest s.r.l." with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA STUDY GROUP" with 1 trials as a collaborator, "Istituto Clinico Humanitas" with 1 trials as a collaborator and "Istituto Toscano Tumori" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "A.O. Universitaria Policlinico Di Modena; Oncologia" are "Breast Cancer" (3 trials), "Leukemia" (3 trials), "Acute Promyelocytic Leukemia" (2 trials), "Renal Cell Carcinoma" (2 trials) and "Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "A.O. Universitaria Policlinico Di Modena; Oncologia" in a lesser frequency.

Most popular intervention types in "A.O. Universitaria Policlinico Di Modena; Oncologia" are "Drug" (26 trials), "Other" (8 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (7 trials), "Placebo" (4 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "A.O. Universitaria Policlinico Di Modena; Oncologia" are 32 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "A.O. Universitaria Policlinico Di Modena; Oncologia". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in A.O. Universitaria Policlinico Di Modena; Oncologia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in A.O. Universitaria Policlinico Di Modena; Oncologia, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".